tiprankstipranks
NovoCure Ltd (NVCR)
NASDAQ:NVCR
US Market
Holding NVCR?
Track your performance easily

NovoCure (NVCR) Financial Statements

1,474 Followers

NovoCure Financial Overview

NovoCure's market cap is currently ―. The company's EPS TTM is $-1.393; its P/E ratio is ―; NovoCure is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 155.09M$ 150.36M$ 138.50M$ 133.78M$ 127.32M
Gross Profit$ 119.72M$ 115.70M$ 104.81M$ 101.23M$ 95.23M
EBIT$ -32.09M$ -33.58M$ -41.52M$ -7.27M$ -58.24M
EBITDA$ -29.63M$ -30.72M$ -38.70M$ -4.54M$ -55.44M
Net Income Common Stockholders$ -30.57M$ -33.38M$ -38.76M$ -47.08M$ -49.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 959.90M$ 951.19M$ 870.15M$ 910.62M$ 921.25M
Total Assets$ 1.22B$ 1.21B$ 1.12B$ 1.15B$ 1.15B
Total Debt$ 675.63M$ ―$ ―$ ―$ ―
Net Debt$ -284.27M$ ―$ ―$ ―$ ―
Total Liabilities$ 861.21M$ 850.42M$ 762.07M$ 783.63M$ 752.65M
Stockholders Equity$ 360.78M$ 361.75M$ 359.36M$ 362.50M$ 393.70M
Cash Flow-
Free Cash Flow$ -307.00K$ -13.17M$ -43.36M$ -21.38M$ -26.57M
Operating Cash Flow$ 10.38M$ -1.72M$ -31.57M$ -14.56M$ -19.31M
Investing Cash Flow$ 10.19M$ -374.44M$ 246.22M$ 98.50M$ 17.26M
Financing Cash Flow$ 100.00K$ 87.32M$ 213.00K$ 1.91M$ 1.17M
Currency in USD

NovoCure Earnings and Revenue History

NovoCure Debt to Assets

NovoCure Cash Flow

NovoCure Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis